Form 4: BioRestorative Therapies Director Acquires Stock Options
SEC Form 4 Filing
David A. Rosa, a director of BioRestorative Therapies, Inc., reports the acquisition of stock options exercisable for 52,632 shares of common stock.
Summary
- On February 14, 2025, David A. Rosa, a director of BioRestorative Therapies, Inc., acquired stock options for 52,632 shares of common stock at an exercise price of $2.46.
- These options vest in twelve nearly equal monthly installments starting March 14, 2025, and continuing monthly until fully vested.
- Rosa directly owns options for 10,490 shares (exercise price $5.08, exercisable from 11/04/2031), 32,028 shares (exercise price $2.91, exercisable from 02/17/2033), and 79,646 shares (exercise price $1.45, exercisable from 02/13/2034).
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing, indicating a neutral sentiment.
Positives
- The acquisition of stock options by a director may signal confidence in the company's future prospects.
Industry Context
This filing is a routine disclosure related to insider transactions and is common for publicly traded companies.
Stakeholder Impact
- The transaction could have a minor positive impact on shareholder sentiment if interpreted as a sign of confidence by the director.
Key Dates
| Date | Description |
|---|---|
| 11/04/2031 | Date from which options for 10,490 shares at $5.08 are exercisable |
| 02/17/2033 | Date from which options for 32,028 shares at $2.91 are exercisable |
| 02/13/2034 | Date from which options for 79,646 shares at $1.45 are exercisable |
| 02/14/2025 | Date of transaction: Director acquired stock options for 52,632 shares at $2.46 |
| 03/14/2025 | First vesting date for the newly acquired stock options |
| 02/18/2025 | Date of Form 4 filing |
| 02/14/2035 | Expiration date for the newly acquired stock options |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.